期刊文献+

Dulaglutide:治疗2型糖尿病新药

下载PDF
导出
摘要 近年来,糖尿病已成为继肿瘤和心脑血管疾病之后第3位严重危害人类健康的慢性疾病^([1-3])。其中2型糖尿病占糖尿病患者的90%。Dulaglutide(商品名Trulicity)是由礼莱公司(Eli Lilly and Company)研发的一种胰高血糖素样肽(glucagonlikepeptide 1,GLP-1)受体激动剂,用于治疗成人2型糖尿病,与其他治疗糖尿病的药物相比,
出处 《河北医科大学学报》 CAS 2015年第12期1480-1482,共3页 Journal of Hebei Medical University
  • 相关文献

参考文献16

  • 1Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence in adults for 2013 and projections for 2035 [J]. Diabetes Res Clin Pract, 2014, 103 (2) :137-149.
  • 2Xu Y, Wang LM, He J, et al, prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013,310 (9) : 948 - 959.
  • 3张国军,郑丽华,孙锡红.妊娠期糖尿病研究进展[J].河北医科大学学报,2015,36(7):862-866. 被引量:53
  • 4Dungan K,Povedono ST,Forst T,et al.Efficacy and Safety of Once Weekly Dulaglufide vs,Once Daily Liraglutide in Type 2 Diabetes (AWARD 6) [J].Can J Diabetes,2014,38(5) :S11.
  • 5Glaesner W, Vick AM, Millican R, et al. Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265,an Fe fusion protein[J].Diabetes Metab Res Rev,2010,26(4) :1287-296.
  • 6Jimenez-Solem E, Rasmussen MH, Christensen M, et al. Dulaglutlde,a Ionwacting GLP-I analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes[J].Curr Opin Mol Ther,2010,12(6):790-797.
  • 7Barrington P, Chien JY, Tibaldi F, et al. LY2189265, a long- acting glucagon-like peptide-1 analogue: showed a dose- dependent effect on insulin secretion ia healthy subjects[J]. Diabetes Obes Metab,2011 ,13(5) :484-438.
  • 8Umpierrez G, Tofg Povedano S, Perez Manghi F, et al. Efficacy and safety Of dulaglutide moaotherapy versus metformin, in type 2 diabetes in a randomized controlled trial (AWARD-3) [J].Diabetes Care, 2014,37 (8) : 2168- 2176,.
  • 9Wysham C, Blevins T, Arakaki R, et al,Effieacy and safety of dulaglutide added onto picalitaaone and metformin versus exenatide in type 2 diahetes in a randomized controlled trial (AWARD-1) [J].Diahetes Care,2014,37(8) :2159-2167.
  • 10Giorgino F, Bearoubi M, Sun J, et al. Efficacy and safety of once-weekly dulaglutide vs. insulin glargine in combination with metformin and glimepiride in type 2 diabetes patients (AWARD-2) [J].Diabetol0gia,2014,53(Suppl 1) :A38.

二级参考文献18

  • 1谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:306.
  • 2Yang H. Wei Y, Gao X, et al. Risk factora for gestationaldiaberes mellitus in Chinese women: a prospective study of16,286 pregnant wonen in China [J]. Diabet Med, 2009 . 26(11):1099-1104.
  • 3Hadar E,Oats J.Hod M.Towards new diagnostic criteria fordiagnosing GDM: the HAPO study[J].J Perinat Med, 2009,37(5):447-449.
  • 4Internationnal Association of Diabetes and Pregnancy StudyGroups Consensus Panel. Metzger BE, Gabbe SG, et al.Internationnal association of diabetes and pregnancy studygroups recommendations on the diagnosis and classification ofhyperglycemia in pregnancy [J]. Diabetes Care, 2010, 33(3):676-682.
  • 5American Diabetes Association.Diagnosis and classification ofdiabetes mellitus[J].Diabetes Care,2011,34(Suppl 1):S62 -69.
  • 6No authors listed. Diagnosis criteria and classification ofhyperglycaemia first detected in pregnancy ; a World HealthOrganization GuidelineQ],Diabetes Res Clin Pract.2014,103(3):341-363.
  • 7HAPO Study Cooperative Research Group, Metzger BE,Lowe LP, et al. Hyperglycemia and adverse pregnancyoutcomes [J],N Engl J Med,2008,358( 19) -.1991 - 2002.
  • 8Landon MB,Spong CY,Thom E,et al. A multicenter,randomized trial of treatment for mild gestational diabetes[J].N Engl J Med,2009,361(14) :1339-1348.
  • 9Gavard JA, Artal R.Effect of exercise on pregnancy outcomes[J].Clin Obstet Gynecol,2008,51(2) :467-480.
  • 10Mathiesen ER,Kinsley B, Amiel SA,et al.Maternal glycemiccontrol and Hypoglycemia in type 1 diabetic pregancy. arandomized trial of insulin aspart versus human insulin in 322pregnant women[J],Diabetes Care,2007,30(4) :771 -776.

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部